Ioanna Stamati

425 total citations
25 papers, 327 citations indexed

About

Ioanna Stamati is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ioanna Stamati has authored 25 papers receiving a total of 327 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ioanna Stamati's work include Monoclonal and Polyclonal Antibodies Research (7 papers), HER2/EGFR in Cancer Research (6 papers) and thermodynamics and calorimetric analyses (5 papers). Ioanna Stamati is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (7 papers), HER2/EGFR in Cancer Research (6 papers) and thermodynamics and calorimetric analyses (5 papers). Ioanna Stamati collaborates with scholars based in United Kingdom, Belgium and Greece. Ioanna Stamati's co-authors include Mahendra P. Deonarain, Gökhan Yahioglu, David R. Phillips, Marina K. Kuimova, Anja Pomowski, Bryan Edwards, Hayley Pye, James Clarke, Filip Logist and Jan Van Impe and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Ioanna Stamati

21 papers receiving 316 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ioanna Stamati United Kingdom 9 138 116 103 99 86 25 327
Yakun Wan China 11 110 0.8× 89 0.8× 83 0.8× 48 0.5× 250 2.9× 17 507
Lukas Deweid Germany 11 158 1.1× 101 0.9× 40 0.4× 44 0.4× 251 2.9× 17 375
Laurie Freire Boullosa Belgium 8 83 0.6× 91 0.8× 64 0.6× 65 0.7× 137 1.6× 11 331
Arnaud Briat France 13 77 0.6× 128 1.1× 27 0.3× 27 0.3× 235 2.7× 23 440
Torsten Klockenbring Germany 10 51 0.4× 93 0.8× 34 0.3× 31 0.3× 148 1.7× 18 376
Chia‐Yu Yu Taiwan 11 138 1.0× 32 0.3× 79 0.8× 54 0.5× 118 1.4× 20 374
Priya Vishnubhotla United States 8 36 0.3× 89 0.8× 47 0.5× 58 0.6× 301 3.5× 17 500
Calise Bahou United Kingdom 11 190 1.4× 165 1.4× 67 0.7× 39 0.4× 189 2.2× 15 391
Eshita Khera United States 12 237 1.7× 223 1.9× 98 1.0× 22 0.2× 191 2.2× 18 487
Rendall R. Strawbridge United States 9 150 1.1× 37 0.3× 148 1.4× 34 0.3× 344 4.0× 24 533

Countries citing papers authored by Ioanna Stamati

Since Specialization
Citations

This map shows the geographic impact of Ioanna Stamati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ioanna Stamati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ioanna Stamati more than expected).

Fields of papers citing papers by Ioanna Stamati

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ioanna Stamati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ioanna Stamati. The network helps show where Ioanna Stamati may publish in the future.

Co-authorship network of co-authors of Ioanna Stamati

This figure shows the co-authorship network connecting the top 25 collaborators of Ioanna Stamati. A scholar is included among the top collaborators of Ioanna Stamati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ioanna Stamati. Ioanna Stamati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stamati, Ioanna, Gökhan Yahioglu, Anja Pomowski, et al.. (2025). Anti-HER2, High-DAR Antibody Fragment–Drug Conjugates with a Glucuronide-Based MMAE Linker–Payload Demonstrate Superior Efficacy over IgG-Based ADCs. Molecular Cancer Therapeutics. 24(9). 1295–1307.
2.
Stamati, Ioanna, et al.. (2022). Clinical application of extended half‐life factor VIII in children with severe haemophilia A. Haemophilia. 28(4). 619–624. 2 indexed citations
3.
Deonarain, Mahendra P., et al.. (2021). Abstract 909: Antibody fragment drug-conjugates (FDCs)-application of ANT-043 and ANT-045 in solid tumors. Cancer Research. 81(13_Supplement). 909–909. 1 indexed citations
4.
Deonarain, Mahendra P., et al.. (2020). Abstract 2901: Gastric cancer antibody fragment drug-conjugates (FDCs): From concept to clinical development. Cancer Research. 80(16_Supplement). 2901–2901. 2 indexed citations
5.
Deonarain, Mahendra P., Gökhan Yahioglu, Ioanna Stamati, et al.. (2018). Small-Format Drug Conjugates: A Viable Alternative to ADCs for Solid Tumours?. Antibodies. 7(2). 16–16. 73 indexed citations
6.
Pye, Hayley, Antoine Maruani, João P. M. Nunes, et al.. (2016). A HER2 selective theranostic agent for surgical resection guidance and photodynamic therapy. Photochemical & Photobiological Sciences. 15(10). 1227–1238. 16 indexed citations
7.
Stamati, Ioanna, Simen Akkermans, Filip Logist, Estefanía Noriega, & Jan Van Impe. (2016). Optimal experimental design for discriminating between microbial growth models as function of suboptimal temperature: From in silico to in vivo. Food Research International. 89. 689–700. 9 indexed citations
8.
Sordi, Luisa De, Hayley Pye, Darina Kohoutová, et al.. (2015). Development of Photodynamic Antimicrobial Chemotherapy (PACT) for Clostridium difficile. PLoS ONE. 10(8). e0135039–e0135039. 21 indexed citations
9.
Deonarain, Mahendra P., et al.. (2015). Emerging formats for next-generation antibody drug conjugates. Expert Opinion on Drug Discovery. 10(5). 463–481. 55 indexed citations
10.
Stamati, Ioanna, Filip Logist, Eva Van Derlinden, Jean-Pierre Gauchi, & Jan Van Impe. (2014). Optimal experimental design for discriminating between microbial growth models as function of suboptimal temperature. Mathematical Biosciences. 250. 69–80. 3 indexed citations
12.
Butt, Mohammed A., Luisa De Sordi, Gökhan Yahioglu, et al.. (2013). Sa1231 Two Phase Photodynamic Antimicrobial Chemotherapy (PACT) Combined With Germinant Therapy Effectively Treats Clostridium difficile and Their Spores That Are Resistant to Antibiotics. Gastroenterology. 144(5). S–236. 1 indexed citations
13.
Baka, Maria, Ioanna Stamati, Estefanía Noriega, Filip Logist, & Jan Van Impe. (2013). Critical assessment of the Time-To-Detection method’s performance to estimate microbial growth parameters. Lirias (KU Leuven). 31–32. 1 indexed citations
15.
Pye, Hayley, et al.. (2013). Antibody-Directed Phototherapy (ADP). SHILAP Revista de lepidopterología. 2(2). 270–305. 31 indexed citations
17.
Stamati, Ioanna, et al.. (2012). Optimal Experiment Design for Calibrating an Airpath Model of a Diesel Engine. SNE Simulation Notes Europe. 22(3-4). 2 indexed citations
18.
Stamati, Ioanna, et al.. (2010). Novel photosensitisers derived from pyropheophorbide-a: uptake by cells and photodynamic efficiency in vitro. Photochemical & Photobiological Sciences. 9(7). 1033–1041. 43 indexed citations
19.
Kuimova, Marina K., Manpreet S. Bhatti, Mahendra P. Deonarain, et al.. (2007). Fluorescence characterisation of multiply-loaded anti-HER2 single chain Fv-photosesitizer conjugates suitable for photodynamic therapy. Photochemical & Photobiological Sciences. 6(9). 933–939. 41 indexed citations
20.
Vazirgiannis, M., et al.. (1998). Interactive multimedia scenario. 462–470. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026